These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38090573)

  • 1. The autoinflammation-associated NLRC4
    Eeckhout E; Asaoka T; Van Gorp H; Demon D; Girard-Guyonvarc'h C; Andries V; Vereecke L; Gabay C; Lamkanfi M; van Loo G; Wullaert A
    Front Immunol; 2023; 14():1272639. PubMed ID: 38090573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three cases of autoinflammatory disease with novel NLRC4 mutations, and the first mutation reported in the CARD domain of NLRC4 associated with autoinflammatory infantile enterocolitis (AIFEC).
    Asna Ashari K; Parvaneh N; Mirnia K; Ayati M; Saeedi M; Salehzadeh F; Shahrooei M; Sangsari R; Rohani P; Ziaee V
    Pediatr Rheumatol Online J; 2024 Oct; 22(1):90. PubMed ID: 39425177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLRC4 inflammasomopathies.
    Romberg N; Vogel TP; Canna SW
    Curr Opin Allergy Clin Immunol; 2017 Dec; 17(6):398-404. PubMed ID: 28957823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Mutation in the NBD Domain of
    Wang L; Wen W; Deng M; Li Y; Sun G; Zhao X; Tang X; Mao H
    Front Immunol; 2021; 12():674808. PubMed ID: 34248956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome.
    Weiss ES; Girard-Guyonvarc'h C; Holzinger D; de Jesus AA; Tariq Z; Picarsic J; Schiffrin EJ; Foell D; Grom AA; Ammann S; Ehl S; Hoshino T; Goldbach-Mansky R; Gabay C; Canna SW
    Blood; 2018 Mar; 131(13):1442-1455. PubMed ID: 29326099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome.
    Canna SW; de Jesus AA; Gouni S; Brooks SR; Marrero B; Liu Y; DiMattia MA; Zaal KJ; Sanchez GA; Kim H; Chapelle D; Plass N; Huang Y; Villarino AV; Biancotto A; Fleisher TA; Duncan JA; O'Shea JJ; Benseler S; Grom A; Deng Z; Laxer RM; Goldbach-Mansky R
    Nat Genet; 2014 Oct; 46(10):1140-6. PubMed ID: 25217959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Disease-associated Mutant of NLRC4 Shows Enhanced Interaction with SUG1 Leading to Constitutive FADD-dependent Caspase-8 Activation and Cell Death.
    Raghawan AK; Sripada A; Gopinath G; Pushpanjali P; Kumar Y; Radha V; Swarup G
    J Biol Chem; 2017 Jan; 292(4):1218-1230. PubMed ID: 27974463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSC70 regulates cold-induced caspase-1 hyperactivation by an autoinflammation-causing mutant of cytoplasmic immune receptor NLRC4.
    Raghawan AK; Ramaswamy R; Radha V; Swarup G
    Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21694-21703. PubMed ID: 31597739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoinflammation: NLRC4 mutation causes rare autoinflammatory disease.
    Bernard NJ
    Nat Rev Rheumatol; 2014 Nov; 10(11):635. PubMed ID: 25266450
    [No Abstract]   [Full Text] [Related]  

  • 10. Recessive NLRC4-Autoinflammatory Disease Reveals an Ulcerative Colitis Locus.
    Steiner A; Reygaerts T; Pontillo A; Ceccherini I; Moecking J; Moghaddas F; Davidson S; Caroli F; Grossi A; Castro FFM; Kalil J; Gohr FN; Schmidt FI; Bartok E; Zillinger T; Hartmann G; Geyer M; Gattorno M; Mendonça LO; Masters SL
    J Clin Immunol; 2022 Feb; 42(2):325-335. PubMed ID: 34783940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin as an Adjunctive Therapy for NLRC4 Associated Macrophage Activation Syndrome.
    Barsalou J; Blincoe A; Fernandez I; Dal-Soglio D; Marchitto L; Selleri S; Haddad E; Benyoucef A; Touzot F
    Front Immunol; 2018; 9():2162. PubMed ID: 30319625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation.
    Romberg N; Al Moussawi K; Nelson-Williams C; Stiegler AL; Loring E; Choi M; Overton J; Meffre E; Khokha MK; Huttner AJ; West B; Podoltsev NA; Boggon TJ; Kazmierczak BI; Lifton RP
    Nat Genet; 2014 Oct; 46(10):1135-1139. PubMed ID: 25217960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NLRC4 gain-of-function variant is identified in a patient with systemic lupus erythematosus.
    Wang Q; Ye X; Zheng W; Jin T; Zhou Y; Hu X; Zhou Q; Yu X
    Clin Immunol; 2023 Oct; 255():109731. PubMed ID: 37567492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoinflammatory mutation in NLRC4 reveals a leucine-rich repeat (LRR)-LRR oligomerization interface.
    Moghaddas F; Zeng P; Zhang Y; Schützle H; Brenner S; Hofmann SR; Berner R; Zhao Y; Lu B; Chen X; Zhang L; Cheng S; Winkler S; Lehmberg K; Canna SW; Czabotar PE; Wicks IP; De Nardo D; Hedrich CM; Zeng H; Masters SL
    J Allergy Clin Immunol; 2018 Dec; 142(6):1956-1967.e6. PubMed ID: 29778503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NLRC4 gets out of control.
    Khameneh HJ; Mortellaro A
    Nat Genet; 2014 Oct; 46(10):1048-9. PubMed ID: 25257084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct Roles of IL-1β and IL-18 in NLRC4-Induced Autoinflammation.
    Sasaki Y; Otsuka K; Arimochi H; Tsukumo SI; Yasutomo K
    Front Immunol; 2020; 11():591713. PubMed ID: 33178225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of NLRC4 is critical for inflammasome activation.
    Qu Y; Misaghi S; Izrael-Tomasevic A; Newton K; Gilmour LL; Lamkanfi M; Louie S; Kayagaki N; Liu J; Kömüves L; Cupp JE; Arnott D; Monack D; Dixit VM
    Nature; 2012 Oct; 490(7421):539-42. PubMed ID: 22885697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition.
    Canna SW; Girard C; Malle L; de Jesus A; Romberg N; Kelsen J; Surrey LF; Russo P; Sleight A; Schiffrin E; Gabay C; Goldbach-Mansky R; Behrens EM
    J Allergy Clin Immunol; 2017 May; 139(5):1698-1701. PubMed ID: 27876626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel NLRC4 Mutation Causes a Syndrome of Perinatal Autoinflammation With Hemophagocytic Lymphohistiocytosis, Hepatosplenomegaly, Fetal Thrombotic Vasculopathy, and Congenital Anemia and Ascites.
    Liang J; Alfano DN; Squires JE; Riley MM; Parks WT; Kofler J; El-Gharbawy A; Madan-Kheterpal S; Acquaro R; Picarsic J
    Pediatr Dev Pathol; 2017; 20(6):498-505. PubMed ID: 28403691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excess Serum Interleukin-18 Distinguishes Patients With Pathogenic Mutations in PSTPIP1.
    Stone DL; Ombrello A; Arostegui JI; Schneider C; Dang V; de Jesus A; Girard-Guyonvarc'h C; Gabay C; Lee W; Chae JJ; Aksentijevich I; Goldbach-Mansky RT; Kastner DL; Canna SW
    Arthritis Rheumatol; 2022 Feb; 74(2):353-357. PubMed ID: 34492165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.